Saudi: Dallah Healthcare records $125.5mln net profit in 2024 on back of 9% higher revenue
Dallah Healthcare Company posted a 30.84% increase in 2024 net profit to SAR 471.20 million, compared with SAR 360.12 million in 2023, according to the financial results.
The positive result is attributed to an 8.93% growth in revenue to SAR 3.20 billion during the January-December 2024 period from SAR 2.94 billion in the same duration a year earlier.
The annual rise in revenue resulted from higher operational capacity, performance efficiency, and continued growth in the number of visitors to the group's hospitals.
Moreover, the earnings per share (EPS) stood at SAR 4.83 in 2024, marking a 30.60% increase from SAR 3.70 in the prior year.
It is worth noting that during the first nine months (9M) of 2024, Dallah Healthcare logged net profits of SAR 357.29 million as well as SAR 2.39 billion worth of revenue.
All Rights Reserved - Mubasher Info © 2005 - 2022 Provided by SyndiGate Media Inc. (Syndigate.info).
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
an hour ago
- Zawya
Central Bank of Egypt unveils $1.81bln T-bills on Thursday
Cairo – The Central Bank of Egypt (CBE) auctioned treasury bills (T-bills) at a total value of EGP 90 billion through two issues on Thursday, 12 June. The first tranche stood at EGP 45 billion, holding a tenor of 182 days until 16 December 2025, according to official data. Issued with the same value, the second offering will mature in 364 days on 16 June 2026. All Rights Reserved - Mubasher Info © 2005 - 2022 Provided by SyndiGate Media Inc. (
Zawya
a day ago
- Zawya
Hong Kong Hosts World's Largest ISSCR Stem Cell Gathering for the First Time
Some 2,400 stem cell and regenerative medicine pioneers convene to chart new frontiers, resulting from bidding efforts of Hong Kong Convention Ambassadors of the Hong Kong Tourism Board HONG KONG SAR - Media OutReach Newswire - 11 June 2025 - Reputed to be a leading research and development (R&D) hub for medical sciences, Hong Kong hosts the world's largest and most significant gathering of stem cell research and regenerative medicine, the International Society of Stem Cell Research (ISSCR) 2025 Annual Meeting. The event is brought to Hong Kong for the first time, thanks to the joint effort of three local universities – The University of Hong Kong, The Chinese University of Hong Kong and the Hong Kong University of Science and Technology, which are appointed organisations under the Hong Kong Convention Ambassador (HKCA) programme of the Hong Kong Tourism Board (HKTB). The four-day meeting held on June 11-14 gathers more than 2,400 local and international experts in stem cell research and regenerative medicine from 58 countries and regions, from Asia to North America, Europe, Australia, the Middle East, and Mainland China. Pioneers share the latest advances in the field, with topics spanning the field of regenerative medicine including topics such as advances in cell therapies, fundamental discoveries, understanding disease processes and more. Dr Peter Lam, HKTB Chairman, said, "The International Society for Stem Cell Research (ISSCR) is a globally leading organisation in medical sciences and research, and its annual meeting is one of the world's most significant international academic conventions in medical science. Hong Kong is the first city chosen to host this annual event in Asia after a 13-year hiatus, underscoring the city's status as the 'World's Meeting Place'. I am grateful for the active participation of the Hong Kong Convention Ambassadors from the three local universities, who leveraged their influence and network during the bidding for the host of the event to make the event come true. We are also delighted to see that more professionals from a wider range of expertise are joining HKTB's league of Convention Ambassadors, and we believe their participation can help identify and contribute to the staging of more significant international events in Hong Kong." Valentina Greco, ISSCR President, remarked, "Hosting ISSCR 2025 in Hong Kong marks a defining moment for global stem cell science. As a vibrant research hub at the crossroads of Asia and the world, Hong Kong offers an ideal setting to connect diverse scientific communities, spark new collaborations, and accelerate innovation. The ISSCR is deeply grateful to the city of Hong Kong and to our generous co-sponsors – the University of Hong Kong, The Chinese University of Hong Kong, and the Hong Kong University of Science and Technology – for their support and commitment to bringing The Global Stem Cell Event to this beautiful city. With the unwavering support of the Hong Kong Tourism Board, these three leading universities, and inspired leadership from our 2025 Annual Meeting Program Committee, this meeting exemplifies the power of partnership and shared vision. We are proud to return to Asia for the first time in more than a decade at a time when our collective progress in stem cell research and regenerative medicine and to advancing therapies that have life altering impact on patients depends on the exchange of bold ideas across borders." The extensive programme features plenary sessions, concurrent tracks, poster presentations, and networking opportunities. Contributing to the success of the event, the HKTB has provided comprehensive support, from arranging reconnaissance to venue sourcing, bid proposal, network support and more. Hong Kong Convention Ambassador Programme Aligns a Record Lineup of 180 Industry Leaders HKCAs have been instrumental in winning the ISSCR 2025 Annual Meeting for Hong Kong. Launched in 2020 by the HKTB as a strategic initiative, the HKCA programme recruits high-level representatives of Hong Kong's eight universities, chambers of commerce, professional organisations, public bodies, industrial entities and professional societies to act as ambassadors for Hong Kong's convention sector. With their professional influence and networks, HKCAs have led efforts to bring in events ranging from medical sciences to innovation and technology (I&T), financial services, aviation, transportation and more. The close collaboration between HKCAs and the HKTB has proven effective in promoting Hong Kong as a premier hub for world-class conventions. As an alliance of distinguished local and Mainland leaders in business, medicine, professional services, I&T and other fields, the HKCA programme has been growing from strength to strength, with 72 new members in the latest record-sized cohort for the 2025-2026 term, taking the total to about 180, some 30% more than the previous cohort. Among the 76 international events for 2025 to 2027 lined up by the HKTB, with an estimated attendance of over 180,000 MICE visitor arrivals and 27 resulted from HKCAs' efforts. The events cover diverse fields ranging from I&T to aviation and medical sciences. Some are held in Hong Kong for the first time, including IEEE Electron Devices Technology and Manufacturing Conference held in March 2025, Routes World in September 2025 and World Cancer Congress 2026. The HKTB is committed to working closely with HKCAs to welcome more world-class events to Hong Kong, attracting high-yield overnight business visitors to the city and reinforcing the city's status as the world's meeting place. Large-scale conventions facilitated by Hong Kong Convention Ambassadors: Date Events (*first-ever in Hong Kong) Theme/Sector March 2025 IEEE Electron Devices Technology and Manufacturing Conference * Innovation & Technology May 2025 IEEE International Conference on Data Engineering Innovation & Technology Jun 2025 International Society for Stem Cell Research (ISSCR) Annual Meeting* Medical sciences Sep 2025 Routes World* Aviation Dec 2025 The International Society of Sport Psychology 16 th World Congress Sports & Medical sciences 2026 Asia-Pacific Association for International Education 2026 Conference and Exhibition Education 2026 17 th Asian Congress of Oral and Maxillofacial Surgery Medical sciences 2026 Asian Venture Philanthropy Network Conference Philanthropy 2026 International Federation of Landscape Architects World Congress Architecture 2026 Lions International Convention Social Services 2026 The Association of National Olympic Committees General Assembly Sports 2026 The Council Meeting of the Asian Patent Attorneys Association Intellectual property 2026 World Cancer Congress* Medical sciences 2027 International Association for Energy Economics Annual International Conference Economics 2027 Lions Clubs International Orient and Southeast Asian Lions Forum Social Services 2027 World Organization of Family Doctors Asia Pacific Regional Conference Medical sciences Hashtag: #HKTB The issuer is solely responsible for the content of this announcement. Hong Kong Tourism Board
Zawya
2 days ago
- Zawya
GIA Redefines Lab-grown Diamond Grading Standards Discontinuation of 4Cs Grading System Enhances Differentiation Between Natural and Lab-Grown Diamonds
HONG KONG SAR - Media OutReach Newswire - 10 June 2025 - The Gemological Institute of America (GIA), the world's foremost authority in gemology announced a redefinition in diamond grading on June 2, 2025. Beginning at the end of 2025, GIA will cease using the internationally recognized 4Cs grading system (Cut, Colour, Clarity, Carat) for lab-grown diamonds. Instead, GIA will implement a new descriptive grading system that lab-grown diamonds submitted to GIA will receive simplified descriptors—categorized broadly as either "premium" or "standard" or no grade at all if the quality is subpar. This transformative change marks a historic shift in the global diamond industry, not only redefining the value perception of lab-grown diamonds but also enhancing the differentiation between natural and lab-grown diamonds. This initiative is not merely a terminology adjustment; it represents a systematic effort to separate the grading systems for lab-grown and natural diamonds. As a non-profit organization, GIA emphasizes the fundamental differences between the two, including their formation processes, physical characteristics, and market values. According to Tom Moses, GIA Executive Vice President and Chief Laboratory and Research Officer, "More than 95% of lab-grown diamonds entering the market fall into a very narrow range of color and clarity. Because of that, it is no longer relevant for GIA to describe man-made diamonds using the nomenclature created for the continuum of color and clarity of natural diamonds." Reaffirming the Unique Value of Natural Diamonds This revision of grading standards is another milestone following GIA's abandonment of the term "Synthetic" and its move to describe lab-grown diamonds in relation to natural diamond standards. GIA created the 4Cs—cut, colour, clarity, and carat weight—as a rigorous system to help consumers understand the unique and qualities of natural diamonds. With the new lab-grown diamond grading system, the core value of natural diamonds—rarity and emotional attributes are further emphasized. No two natural diamonds are exactly alike. Every natural diamond is unique, characterized by its distinct growth patterns, inclusions, and colour formed over billions of years. These nature's treasures, formed deep within the Earth, are considered valuable collectibles due to their beauty, rarity and non-renewability. They symbolize values associated with love, commitment, and eternity, while also contributing to the social and economy welfare of the diamond mining communities through responsible mining practices. In contrast, lab-grown diamonds are man-made and mass-produced using high-pressure high-temperature (HPHT) or Chemical Vapor Deposition (CVD) processes. Their industrial nature limits their ability to embody the multiple values associated with natural diamonds, including emotional attributes, rarity, investment potential, and heritage. GIA's reform not only reaffirms the irreplaceable status of natural diamonds but also clarifies that lab-grown diamonds should not be assessed using the same criteria as natural diamonds. Ensuring Consumer Awareness and Transparency Over time, some lab-grown diamond sellers have been using ambiguous marketing terms such as "sustainability" and "equivalency" that may mislead consumers about the differences between lab-grown and natural diamonds. GIA's new approach ensures consumers can make informed choices without confusion, protecting their rights to knowledge, choice, and fair trade. By discontinuing the use of the 4Cs standard for lab-grown diamonds, GIA reaffirms its commitment to scientific integrity and public transparency. GIA's grading redefinition is poised to have a profound impact on the global jewellery industry. As this change takes effect by the end of 2025, it is anticipated that gemological institutes worldwide will follow suit. The boundaries between natural and lab-grown diamonds are clearly defined through GIA's new grading standards. Hashtag: #GIA #NaturalDiamonds #LabGrownDiamonds #DiamondCertification #DiamondGrading The issuer is solely responsible for the content of this announcement. A Diamond is Forever
